Concepedia

Ann D. Kwong

AD

Statistics

Publications

50

Citations

7.8K

H-Index

34

Active since

1982

Affiliations

Vertex Pharmaceuticals (United States)(Current)

University of Chicago

Memorial Sloan Kettering Cancer Center

Université Paris Cité

Inserm

Ann D. Kwong is an author at Vertex Pharmaceuticals (United States) specializing in molecular virology, virology, and life sciences.

ORCID

Publications per year

1982–2023

50

Publications

50

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2009 · 1K citations

, , +12

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

Christoph Sarrazin, Tara L. Kieffer, Doug J. Bartels et al. · Gastroenterology · 2007 · 614 citations · Full text

, , +17

Structure of the hepatitis C virus RNA helicase domain

Nanhua Yao, Thomas Hesson, Michael Cable et al. · Nature Structural Biology · 1997 · 446 citations

, , +10

Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease

Robert B. Perni, Susan J. Almquist, Randal A. Byrn et al. · Antimicrobial Agents and Chemotherapy · 2006 · 387 citations · Full text

, , +17

Telaprevir and pegylated interferon–alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

Tara L. Kieffer, Christoph Sarrazin, Janice S. Miller et al. · Hepatology · 2007 · 378 citations

, , +17

1–5 of 50